Now Offering the Latest Advancement in Glaucoma Treatment
We are excited to announce that we are now offering the CyPass Micro-Stent, the latest advancement in glaucoma treatment, for patients with mild-to-moderate open-angle glaucoma and cataracts. The CyPass Micro-Stent works by creating a permanent opening through the blockage in the eye’s drainage system to improve the eye’s fluid outflow, resulting in lower eye pressure. The stent is implanted in your eye at the same time you undergo cataract surgery.
In a clinical study of the CyPass Micro-Stent, 72% of patients saw their eye pressure lowered by 20% or more and 93% of those who responded to treatment were drop free after 2 years. This Minimally Invasive Glaucoma Surgery offers patients the advantage of better control of glaucoma and as well as a possibly reducing the need for costly glaucoma medication.